Background and Aim: Gastrointestinal (GI) diseases account for substantial morbidity, mortality, and health care utilization. This public hospital-based study assessed the incidence and time trend of hospitalization and mortality of major GI diseases over one decade. Methods: We conducted an observational study using population-wide database managed by the Hong Kong Hospital Authority with a principal diagnosis of GI diseases defined by International Classification of Disease, 9th Revision, Clinical Modification coding. We measured age-standardized incidence of hospitalization, emergency admissions, multiple admissions, and in-hospital mortality from 2005 to 2014 using Poisson regression. Results: The annual incidence of hospitalization for GI diseases increased from 4713 to 5241 per 100 000 discharges (incidence rate ratio [IRR] = 1.004; 95% confidence interval [CI]: 1.003-1.005). GI infections and cancers showed the highest rates of hospitalization in 2014. Hospitalization for GI cancers (IRR = 1.014; 95% CI: 1.013-1.016) and noninfectious enterocolitis (IRR = 1.058; 95% CI: 1.055-1.061) increased, whereas peptic ulcer disease has decreased. Hospitalization for Crohn's disease showed the most significant rise (126%). Annual incidence of hospitalization for Clostridium difficile infections increased by fivefold (IRR = 1.221; 95% CI: 1.178-1.266), while a 66% reduction was observed for peptic ulcer bleeding (IRR = 0.894; 95% CI: 0.889-0.899). GI cancers had the highest in-hospital mortality rate in 2014, especially colorectal cancer and gastric cancer. Conclusions: This study showed an increased hospitalization burden of GI cancers and Crohn's disease, and a reduction in overall mortality for GI diseases. These data provide insight into epidemiological changes of GI diseases in the 21st century and implications for hospital burden and need of resource re-allocation.
Introduction
Gastrointestinal (GI) diseases are highly prevalent worldwide leading to substantial morbidity and health care utilization.
1,2 They account for approximately 8 million deaths per year worldwide. In the USA, GI diseases affect 60-70 million citizens annually, 3 with the National Institutes of Health devoting up to $1.6 billion to GI research in 2015. Because of this, epidemiologic data estimating disease burden are important for public health research, education, and resource allocation.
The epidemiology of GI diseases has changed over the past decade. Several large population-based studies in the USA provide important time trend information regarding the burden and health care expenditure of GI diseases. [4] [5] [6] However, there are no large-scale population-based incidence data of hospitalization of GI diseases outside the USA. Recently, epidemiology of GI diseases has changed in Asia-Pacific with a decreasing incidence of peptic ulcer disease (PUD) and a rise of non-infectious enterocolitis and GI malignancies. 7 Such changes mirrored the observation that took place in the West and most likely relate to improved hygiene, growing affluence, and rapid urbanization. 8 In this study, we assessed the incidence of hospital admissions and in-hospital mortality for all major GI diseases using data from the Hong Kong Hospital Authority that manages 42 public hospitals serving 90% of the population and is responsible for 87% of the hospital beds in Hong Kong. 9, 10 The information obtained not only serves as a valuable reference for funding agencies and policy-makers but also allows comparison in GI disease burden in Asia to that of our Western counterparts and highlights important questions for future research.
Methods
Data source. This study utilized the electronic medical records from Clinical Data Analysis and Reporting System (CDARS) of Hong Kong Hospital Authority, the sole public-funded health care provider of Hong Kong. All public hospitals in Hong Kong use the computerized Clinical Management System to record all key clinical information, and the data will be stored in CDARS. 11 All patient records in CDARS were anonymized and assigned a unique reference number, which we used to facilitate data retrieval. The study protocol was approved by the Institutional Ethics Review Board of the Chinese University of Hong Kong.
Study design. We performed a public hospital-based retrospective observational study using CDARS and identified GI diseases using the International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM), which has been adapted by all Hong Kong public hospitals since 1996. Because ICD-9-CM codes contain over 14 000 diagnosis codes, we summarized them into six clinically relevant GI groups and 23 subgroups focusing on medical GI diseases. In particular, the GI neoplasm group includes only the diagnoses of malignant neoplasms. We retrieved admission data of patients with a principal diagnosis that fits into our selected GI disease groups. The principal diagnosis recorded on CDARS reflects the diagnosis that the attending physician determines to be the primary cause of admission. We extracted a total of 873 346 discharges, from January 1, 2005, to December 31, 2014. We collected total hospitalizations in Hong Kong for each year from CDARS for age-standardization calculation.
Analysis. For incidence rate, we counted all admissions for GI diseases within the year. We performed a direct agestandardization using World Health Organization standard population for 2000-2025. Age-standardization eliminates the confounding effect of age on disease trends. The World Health Organization standard population uses age brackets of 5 years apart, with each age group having a given weight used for agestandardization (Table S1 ). However, CDARS records patients' age of 15 to 44 into a single group; thus, we combined the weights of all the ages within that range for calculation (Table S2) . Data organization and analysis were performed using (Microsoft, Redmond, WA, USA).
The emergency admission rate was based on patients admitted through the Accident and Emergency department, including those who did not require further admission and was discharged from the emergency room. In-hospital mortality was defined as the total number of inpatient deaths associated with the relevant principal diagnosis. Multiple admission rate was calculated by including all discharge entries from the same patient with the same ICD-9-CM principal diagnosis for more than once within the year. The formulae used for each analysis are summarized as follows:
Statistical analysis. Statistical analyses were performed using The R Project for Statistical Computing. Poisson regression, a common regression model in epidemiology studies involving count data, was performed for all of our analysis to calculate the annual incidence rate ratios (IRRs). For annual percentage change (APC), (Joinpoint Trend Analysis Software, National Cancer Institute, Bethesda, MD, USA) was used to analyze the trend of the GI diseases over 10 years.
12 P-value threshold is 0.00167 after Bonferroni correction for 30 groups of disease. The smallest non-zero P-value R calculated is 2.22 × 10 À308 , and any smaller P-values will hence be reported as "P < 2.22 × 10 À308 ."
Results
Hospitalizations. The mean annual age-adjusted incidence of hospitalization for all GI diseases was 5539 per 100 000 people over 10 years. by GI neoplasms (Table S3 ). In 2014, there were 1836 discharges for GI infections and 1620 discharges for GI neoplasms, contributing more than 60% of total discharges of GI diseases ( Table 1 ).
There is a significant reduction of 66% for PUD-related bleeding over 10 years (IRR = 0.894; 95% CI: 0.889-0.899) ( Table 1 , Fig. 1 ).
Of particular note, Clostridium difficile infections increased by more than fivefold (IRR = 1.221; 95% CI: 1.178-1.266) ( Table 1 , Fig. 1 ) out of the 31% rise in bacterial GI infections (Table 1) .
Annual percentage change. The APC was also calculated using our data, and it demonstrated a great decline (27.34%, P = 0.0013) for viral hepatitis B during the years 2012-2014.
There was also regression in the incidences of PUD with hemorrhage from 2011 to 2014 (15.24%, P = 0.0016) and of GI neoplasms from 2009 to 2014 (2.39%, P = 0.0167) (Table S9 , Fig. 2 ). The year of trend change was also identified for specific diseases, whereby the incidence showed a turning point. (Table S9 ).
In-hospital mortality. The overall in-hospital mortality of GI diseases was reduced from 7.2% to 5.0% over the past 10 years (IRR = 0.959; 95% CI: 0.956-0.962) (Table S4) . GI infections had the lowest in-hospital mortality in 2014 with 300 deaths per 100 000 patients. GI neoplasms had the highest in-hospital mortality rate of 8100 deaths per 100 000 patients in 2014. In particular, hepatobiliary and pancreatic cancer had the highest in-hospital mortality rate of 12 950 per 100 000, followed by esophageal cancer (10 920 per 100 000) and small intestinal cancer (9870 per 100 000). However, the in-hospital mortality for GI neoplasms showed a decreasing trend and reduced by 40% Table S5 ). The average length of stay is also provided in Table S8 .
Emergency department visits. We looked at percentage of emergency admissions to the total number of hospital discharges for each GI disease. Emergency admissions for overall GI diseases have decreased by 14% (IRR = 0.982; 95% CI: 0.981-0.983) ( 
Discussion
This study reported, for the first time, hospital burden of GI diseases in Hong Kong over 10 years. GI neoplasms and GI infections were the leading causes of hospitalization, with over 1500 discharges per year. Colorectal cancer was the most prevalent cancer with a 34% increase in hospitalization, 13, 14 whereas C. difficile infections related hospitalizations increased by fivefold over the decade-both are potential emerging GI diseases. In contrast, PUD-related bleeding decreased by 66%. These data, derived from one of the most comprehensive nationwide database in Hong Kong, highlight the current challenges of GI diseases in newly industrialized countries. In particular, colorectal cancers accounted for more than half of all malignant GI neoplasms admissions. This is consistent with epidemiological trends reported from several large-scale studies in the West. [1] [2] [3] [4] In the USA, an estimated 136 830 people were diagnosed with colorectal cancer in 2014 with rising trends. Hospital admissions for Crohn's disease in the USA also increased during the last 20 years, whereas C. difficile hospitalizations have increased by 237% since 2000.
1,2
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The Hong Kong Cancer Registry shows that over 4500 people were diagnosed with colorectal cancer in 2013. 13 The increased colorectal cancer admission suggests a rise in disease prevalence. 15 Numerous explanations have been suggested, including obesity, smoking, increased consumption of red meat, and preserved food, [16] [17] [18] as well as early detection of cancer Gastrointestinal diseases in HKprecursor lesions and increasing cancer awareness. The decreased in-hospital mortality rate of colorectal cancer may relate to increased implementation of screening. 19, 20 Based on our current data and previous studies, non-infectious enterocolitis, in particular, Crohn's disease, has become more prevalent, with a chronic and relapsing nature leading to multiple admissions. 21 The emergence of Crohn's disease may relate to Westernization of lifestyles, with increasing consumption of protein-carbohydrate-rich foods. 21, 22 Hospital admissions and associated costs for inflammatory bowel disease also increased in last 20 years in the USA. 23, 24 Conversely, emergency hospital admissions for Crohn's disease are decreasing. This agrees with a population-based study in Canada and may relate to the increase and earlier use of immunosuppressive therapies. 25, 26 Clostridium difficile infections are commonly associated with antibiotics use. 27 China contributes nearly half of the world's total antibiotics consumption. 28 Multiple antibiotics are also detected in urine of children in China. 29 These may relate to the increased incidence of C. difficile infections in Hong Kong. Other epidemiological studies in the USA, Korea, Taiwan, and Singapore also showed similar trends in C. difficile infection, 30, 31 posing a global challenge, and newer strategies for rationalization of antibiotic use are necessary to control this "epidemic."
31
Hospitalizations for PUD-related bleeding have dropped over 10 years, which may be reasoned by eradication of Helicobacter pylori or increased use of proton pump inhibitors. 7, 32 This is supported by similar data in Taiwan, with a 202% increase in prescription of H. pylori eradication therapy and a 10-fold increase in proton pump inhibitors use. 7 The top three deadliest GI cancers were colorectal cancer, hepatobiliary and pancreatic cancers, and gastric cancers. The overall in-hospital mortality rates of all GI neoplasms demonstrated significant reduction over the decade with the turning point in 2009. Gastric cancer and colorectal cancer dropped by 44% and 43%, respectively. Again, with the calculations from our APC, we have identified that the tipping point for gastric cancer is in 2009; before that, the APC was 10.49%. It dropped to À2.07% after 2009. The decrease in gastric cancer in-hospital mortality may be due to early detection, perioperative chemotherapy, and improved surgical techniques. 33 Emergency admissions for GI infections and liver diseases have increased significantly. Hepatitis C infections have shown a 76% increase in emergency admissions (Table S6) . Currently, the prevalence of hepatitis C in Hong Kong remains low, and 90% are asymptomatic and thus do not receive any treatment. 34 For multiple admission rates, we observed an increase for nearly all GI diseases, with the largest increase for GI neoplasms, PUD, and non-infectious enterocolitis. Both advanced age and low socioeconomic status are major factors associated with more multiple admissions. 35, 36 Therefore, aging population and increasing trend of Gini coefficient in Hong Kong may explain for the increased multiple admissions.
This study has several strengths. It represents the first public hospital-based comprehensive data reflecting hospital burden of GI diseases in Asia, over a course of 10 years. Our data represent Hong Kong inpatient population because the public sector covers over 87% of in-hospital beds in Hong Kong. Our population is largely homogenous consisting of approximately 94% of Han Chinese; thus, these findings are representative of the Chinese population in China, Taiwan, etc. Age-standardization allows our incidence data to be comparable with other populations. Our study also examined multiple important outcomes related to health care burden including incidence of hospitalization, length of hospital stay, in-hospital death, emergency admission, and multiple admission rate. These findings have significant implications for resource allocations. There are some limitations. First, our data rely on completeness and accuracy of clinical data documentation in CDARS. While ICD-9-CM code is extensive and well adapted by Hong Kong since 1996, there is a lack of studies on validation of CDARS records against information from case notes. Meanwhile, CDARS has been widely used tool in different epidemiological studies. 37, 38 Second, our findings cannot define a causal relationship for the trends observed. In addition, while it is presumed that providers will put the diagnosis with the highest significance or highest cost as principal diagnosis, there are still limitations for fully capturing hospital burden for some complex diseases whereby patients may be admitted with a principal diagnosis for a disease complication with ICD-9-CM codes that are not captured by our study. For example, ascites or variceal bleeding are not a diagnosis under ICD-9-CM code 571 for chronic liver disease and cirrhosis. Lastly, death rate in our study was based on patients with selected GI disease as principal diagnosis recorded as dead in hospital by CDARS. While the cause of episode death during hospitalization was presumed to be secondary to patient's principal GI diagnosis, it only measures in-hospital death associated with each GI disease and may not reflect population mortality rate.
In conclusion, we have shown a comprehensive and updated estimate of in-hospital burden from GI diseases and identified increased incidences of hospitalization for GI neoplasms especially colorectal cancer, Crohn's disease, and C. difficile infection. We identified a reduction in mortality and emergency admissions over the decade, for both GI neoplasms and non-infectious enterocolitis. These data provide new insights to policy-makers and clinicians on hospital burden of emerging GI diseases and highlight evolving disease trends and need of health policy planning. CI, confidence interval; GI, gastrointestinal; IRR, incidence rate ratio; n.s., not significant.
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